Back to Results

A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Scope

National

Location

Rocky Mountain Regional VA Medical Center

Principal Investigator
Daniel Bowles,  MD

Daniel Bowles, MD

Study ID

Protocol Number: 19-2640

More information available at ClinicalTrials.gov: NCT03742895

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers